Evidence map›Paper›PMID 37282782›Full record

ArticleClinical and translational medicine2023

Genomic features, evolutionary patterns and minimal residual disease at surgical margins as novel prognostic/predictive biomarkers in locally advanced rectal cancer.

Kewen He, Li Li, Aijie Li, Yang Xu, Jiaohui Pang, Dianbin Mu, Jie Ma, Hong Ge, Aurian Maleki, Xueting Qin and 5 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Kewen HeDepartment of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, China.ORCID https://orcid.org/0000-0003-0068-7191
Li LiDepartment of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, China.
Aijie LiShanghe County People's Hospital, Jinan, China.
Yang XuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.ORCID https://orcid.org/0000-0003-1670-6131
Jiaohui PangGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Dianbin MuDepartment of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Jie MaDepartment of Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Hong GeDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Aurian MalekiDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Xueting QinSchool of Medicine, Nankai University, Tianjin, China.
Xian ZhangGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Qiuxiang OuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Yang ShaoGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Jinming YuDepartment of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, China.
Shuanghu YuanDepartment of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, China.ORCID https://orcid.org/0000-0002-8327-2524
Shandong Tumor Hospital · CNGenesee Community College · USZhengzhou University · CNNanjing Medical University · CNNankai University · CNShangqiu First People's Hospital · CNThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Margins of ExcisionRectal NeoplasmsBiomarkersGenomicsHumansNeoplasm, ResidualPrognosisBiomarkers

Identifiers

PMID37282782
PMCPMC10246683
OpenAlexW4379598843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.